Genetics study recruits 20,000th participant

A British-based genetics study that aims to improve heart disease prediction has recruited its 20,000th participant.

The Genetics and Vascular Health Check study (GENVASC) is investigating if the addition of genetic information can better improve risk prediction of coronary artery disease (CAD).

Now the team of researchers from the University of Leicester and NIHR Leicester Cardiovascular Biomedical Research Unit (LCBRU), working with Primary Care and Leicester and Leicestershire CCGs, have taken on their 20,000th participant.

Chris Greengrass, project manager of the study at the University of Leicester, said: “The GENVASC study capitalises on the unique opportunity provided by the NHS Health Check Programme, which is being widely promoted within Leicester and Leicestershire and specifically targets people aged 40-74 years who are free of cardiovascular disease.

“People taking part in the health check are simply asked to consent to provide an additional sample of blood at the time of their appointment so we can determine whether the addition of genetic information improves our ability to predict their risk for coronary disease.”

Participants’ health outcomes can be followed up and matched to genetic variants that are known to affect a person’s risk of CAD.

Professor Sir Nilesh Samani, professor of cardiology at the University of Leicester, director of the Leicester Cardiovascular Biomedical Research Unit and chief investigator of the study, said: “Using a simple, cost effective method for collecting genetic information, we are able to follow patients and see how their cardiovascular health is influenced by their genes.

"This means that in the future, people may be treated much earlier and more effectively through clearly targeted and tailored interventions.”

[GENVASC]

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index